Healthcare provider profile · identity verified

James L Flowers, M.D.

Internal Medicine · PAHRUMP, NV · NPI 1649310921

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	499	158
Lisinopril	Lisinopril	456	141
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	374	66
Levothyroxine Sodium	Levothyroxine Sodium	369	101
Amlodipine Besylate	Amlodipine Besylate	337	116
Rosuvastatin Calcium	Rosuvastatin Calcium	270	94
Metoprolol Succinate	Metoprolol Succinate	234	71
Losartan Potassium	Losartan Potassium	229	80
Gabapentin	Gabapentin	221	69
Metformin Hcl	Metformin Hcl	219	64
Omeprazole	Omeprazole	209	71
Alprazolam	Alprazolam	199	34
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	172	27
Tamsulosin Hcl	Tamsulosin Hcl	172	54
Oxycodone Hcl	Oxycodone Hcl	170	25
Metoprolol Tartrate	Metoprolol Tartrate	169	57
Chlorthalidone	Chlorthalidone	166	56
Pantoprazole Sodium	Pantoprazole Sodium	162	50
Potassium Chloride	Potassium Chloride	162	68
Trazodone Hcl	Trazodone Hcl	150	48
Furosemide	Furosemide	128	49
Finasteride	Finasteride	122	35
Prednisone	Prednisone	122	48
Tramadol Hcl	Tramadol Hcl	117	28
Escitalopram Oxalate	Escitalopram Oxalate	110	34
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	108	23
Metformin Hcl Er	Metformin Hcl	107	42
Jardiance	Empagliflozin	102	30
Albuterol Sulfate Hfa	Albuterol Sulfate	100	31
Azithromycin	Azithromycin	100	42
Fluticasone Propionate	Fluticasone Propionate	97	34
Diazepam	Diazepam	95	16
Zolpidem Tartrate	Zolpidem Tartrate	92	17
Ozempic	Semaglutide	90	26
Carvedilol	Carvedilol	84	27
Eliquis	Apixaban	83	29
Hydrochlorothiazide	Hydrochlorothiazide	82	25
Pravastatin Sodium	Pravastatin Sodium	76	22
Triamcinolone Acetonide	Triamcinolone Acetonide	74	31
Lorazepam	Lorazepam	73	19
Clopidogrel	Clopidogrel Bisulfate	66	23
Ondansetron Odt	Ondansetron	66	20
Sildenafil Citrate	Sildenafil Citrate	64	20
Allopurinol	Allopurinol	63	17
Pioglitazone Hcl	Pioglitazone Hcl	59	21
Tizanidine Hcl	Tizanidine Hcl	59	15
Temazepam	Temazepam	58	suppressed
Citalopram Hbr	Citalopram Hydrobromide	55	17
Clonazepam	Clonazepam	55	suppressed
Alendronate Sodium	Alendronate Sodium	52	16
Spironolactone	Spironolactone	52	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	51	13
Pregabalin	Pregabalin	51	14
Famotidine	Famotidine	50	16
Morphine Sulfate Er	Morphine Sulfate	48	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	47	16
Ezetimibe	Ezetimibe	47	17
Warfarin Sodium	Warfarin Sodium	46	13
Diclofenac Sodium	Diclofenac Sodium	45	22
Duloxetine Hcl	Duloxetine Hcl	43	15
Hydroxyzine Hcl	Hydroxyzine Hcl	42	17
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	42	13
Symbicort	Budesonide/Formoterol Fumarate	40	15
Baclofen	Baclofen	39	11
Xarelto	Rivaroxaban	37	11
Montelukast Sodium	Montelukast Sodium	36	12
Simvastatin	Simvastatin	36	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	33	suppressed
Meclizine Hcl	Meclizine Hcl	33	15
Repatha Syringe	Evolocumab	32	suppressed
Clonidine Hcl	Clonidine Hcl	31	14
Doxepin Hcl	Doxepin Hcl	30	suppressed
Ropinirole Hcl	Ropinirole Hcl	30	suppressed
Sertraline Hcl	Sertraline Hcl	30	11
Testosterone Cypionate	Testosterone Cypionate	30	suppressed
Ibuprofen	Ibuprofen	29	11
Mirtazapine	Mirtazapine	29	suppressed
Primidone	Primidone	29	suppressed
Bupropion Xl	Bupropion Hcl	28	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	28	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	28	suppressed
Nitroglycerin	Nitroglycerin	28	18
Atenolol	Atenolol	27	suppressed
Glimepiride	Glimepiride	27	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	27	suppressed
Repatha Sureclick	Evolocumab	27	suppressed
Indapamide	Indapamide	26	suppressed
Lovastatin	Lovastatin	26	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	26	suppressed
Lactulose	Lactulose	25	suppressed
Trulicity	Dulaglutide	25	suppressed
Ondansetron Hcl	Ondansetron Hcl	24	suppressed
Bumetanide	Bumetanide	23	suppressed
Ibu	Ibuprofen	23	suppressed
Meloxicam	Meloxicam	23	suppressed
Amoxicillin	Amoxicillin	22	11
Methadone Hcl	Methadone Hcl	22	suppressed
Benazepril Hcl	Benazepril Hcl	21	suppressed
Glipizide Er	Glipizide	21	suppressed
Glipizide	Glipizide	20	suppressed
Hydralazine Hcl	Hydralazine Hcl	20	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	20	suppressed
Digoxin	Digoxin	19	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	19	suppressed
Farxiga	Dapagliflozin Propanediol	19	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	19	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	18	suppressed
Levetiracetam	Levetiracetam	18	suppressed
Donepezil Hcl	Donepezil Hcl	17	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Ramipril	Ramipril	17	suppressed
Spiriva Respimat	Tiotropium Bromide	17	suppressed
Sps	Sodium Polystyrene Sulfon/Sorb	17	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	16	suppressed
Nifedipine Er	Nifedipine	16	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	15	suppressed
Lidocaine-Prilocaine	Lidocaine/Prilocaine	15	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	15	11
Soliqua 100-33	Insulin Glargine/Lixisenatide	15	suppressed
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	14	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	14	suppressed
Valsartan	Valsartan	14	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	13	suppressed
Cefuroxime	Cefuroxime Axetil	13	suppressed
Creon	Lipase/Protease/Amylase	13	suppressed
Eszopiclone	Eszopiclone	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Lidocaine	Lidocaine	13	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	13	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	12	suppressed
Cilostazol	Cilostazol	12	suppressed
Entresto	Sacubitril/Valsartan	12	suppressed
Hydrocortisone	Hydrocortisone	12	suppressed
Loperamide	Loperamide Hcl	12	suppressed
Prolia	Denosumab	12	suppressed
Ranolazine Er	Ranolazine	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Amiodarone Hcl	Amiodarone Hcl	11	suppressed
Droplet Insulin Syringe	Syringe And Needle,insulin,1ml	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Mupirocin	Mupirocin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error